Burzynski Update: Texas Hearings End, Judges Sifting Evidence | Pocketmags.com

Shopping Cart -

Your cart is currently empty.
Upgrade to today
for only an extra Cxx.xx

You get:

plus This issue of xxxxxxxxxxx.
plus Instant access to the latest issue of 290+ of our top selling titles.
plus Unlimited access to 25000+ back issues
plus No contract or commitment. If you decide that PocketmagsPlus is not for you, you can cancel your monthly subscription online at any time. Auto-renews at €10,99 per month, unless cancelled.
Upgrade Now for €10,99 Learn more
This website use cookies and similar technologies to improve the site and to provide customised content and advertising. By using this site, you agree to this use. To learn more, including how to change your cookie settings, please view our Cookie Policy
Pocketmags Digital Magazines
IT
Pocketmags Digital Magazines
   You are currently viewing the Italy version of the site.
Would you like to switch to your local site?
Leggi ovunque Read anywhere
Modalità di pagamento Pocketmags Payment Types
Trusted site
A Pocketmags si ottiene
Fatturazione sicura
Ultime offerte
Web & App Reader
Regali
Loyalty Points

Burzynski Update: Texas Hearings End, Judges Sifting Evidence

August 2016 saw the end of arguments in the administrative hearing following disturbing allegations by the Texas Medical Board about Stanislaw Burzynski’s Houston cancer clinic. Burzynski, the discoverer, manufacturer, sole U.S. prescriber, and sole U.S. dispenser of a cancer treatment he calls “antineoplastons,” has been treating patients with his unproven therapy for forty years. For the past two decades, Burzynski has administered his drug under the auspices of dozens of FDA-approved clinical trials, none of which has been able to answer whether or not antineoplastons are effective. Participation in the trials, which are generally not covered by insurance, can cost patients hundreds of thousands of dollars. (See “The Burzynski Battles: Four Decades of Unproven Cancer Cure Claims,” SI, March/April 2014.)

READ MORE
Purchase options below
Find the complete article and many more in this issue of Skeptical Inquirer - Nov Dec 2016
If you own the issue, Login to read the full article now.
Single Issue - Nov Dec 2016
€3,49
Or 349 points
Annual Digital Subscription
Only € 3,16 per issue
SAVE
9%
€18,99
Or 1899 points

View Issues

About Skeptical Inquirer

40TH ANNIVERSARY CELEBRATION PART II ODYSSEYS SCIENTIFIC SKEPTICISM NUCLEAR POWER and the Psychology of Evaluating Risk MICHAEL MANN and the Climate Wars Superstition Masquerading as Science